Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Deoxyspergualin in Renal Transplant Patient With Chronic Rejection

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Chronic rejection defined by Banff 2007 criteria~Exclusion Criteria:~* Patients who have recurrent renal diseases and virus-associated renal diseases~* Patients who have initial WBC \< 4,000, neutrophil \< 1,000 , platelet \< 50,000 or Hb \< 8g~* Patients who have acute or chronic infection

- Gender: ALL
- Minimum Age: 11 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Deoxyspergualin, Treatment, (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).